TS
TerrAscend Corp.
TSNDF · OTC
$0.68 +3.56% (+$0.02)
1M +9.00%
Market Cap $243.8M
P/E Ratio -
Div. Yield -
ROE 46.00%
Bulios Fair Price
$0.82
21.0% upside
Current Price
$0.68
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TSNDF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
91 /100
Cheap EV/EBITDA 8.14x
P/FCF 12.53x
P/S 0.95x
Growth
22 /100
Declining Rev. growth 1.68%
Book val. growth 39.12%
EPS growth N/A
Profitability
58 /100
Moderate Gross margin 52.82%
FCF margin 7.62%
Net margin 16.15%
Quality
6 /100
Poor ROIC 62.77%
Asset turnover 0.46x
ROE 46.00%
Debt
26 /100
High Debt/Equity 3.06x
Net debt/EBITDA 3.69x
Current ratio 1.83x
Stability
29 /100
Unstable Beta 2.02x
Profitable years 0
Rev. volatility 22.28%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TSNDF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ziad Ghanem
Employees
1,038
Headquarters
Mississauga
Upcoming events
05 NOV
Earnings
Upcoming earnings report